Author:
Wallace Charles H.,Oliveros Giovanni,Xie Lei,Serrano Peter,Rockwell Patricia,Figueiredo-Pereira Maria
Abstract
AbstractAlzheimer’s disease (AD) is the major form of dementia prevalent in older adults and with a high incidence in females. Identification of early biomarkers is essential for preventive intervention to delay its progression. Furthermore, due to its multifactorial nature, a multi-target approach could be therapeutically beneficial. Our studies included 4- (pre-pathology) and 11-month (mild-pathology) TgF344-AD rats, a transgenic Alzheimer’s model that exhibits age-dependent AD progression. We identified two potential early biomarker genes for AD, early growth response 2 (EGR2) and histone 1H2AA (HIST1H2AA), in the hippocampus of 4-month females. Out of 17,168 genes analyzed by RNA sequencing, expression of these two genes was significantly altered in 4-month TgF344-AD rats compared to wild-type littermates. We also evaluated co-treatment with diazoxide (DZ), a potassium channel activator, and dibenzoylmethane (DIB), which inhibits eIF2α-P activity, on TgF344-AD and wild-type rats. DZ/DIB-treatment mitigated spatial memory deficits and buildup of hippocampal Aβ plaques and tau PHF in 11-month TgF344-AD rats but had no effect on wild-type littermates. To our knowledge, this preclinical study is the first to report EGR2 and HIST1H2AA as potential AD biomarkers in females, and the benefits of DZ/DIB-treatment in AD. Evaluations across multiple AD-related models is warranted to corroborate our findings.
Publisher
Springer Science and Business Media LLC
Reference57 articles.
1. Gaugler, J., Bryan James, T., Reimer, J. & Weuve, J. Alzheimer’s Association. 2021 Alzheimer’s Disease Facts and Figures. Alzheimer’s Dementia: Chicago, IL, USA 17 (2021).
2. Butterfield, D. A., Drake, J., Pocernich, C. & Castegna, A. Evidence of oxidative damage in Alzheimer’s disease brain: Central role for amyloid β-peptide. Trends Mol. Med. 7, 548–554. https://doi.org/10.1016/S1471-4914(01)02173-6 (2001).
3. Salminen, A., Kauppinen, A., Suuronen, T., Kaarniranta, K. & Ojala, J. ER stress in Alzheimer’s disease: A novel neuronal trigger for inflammation and Alzheimer’s pathology. J. Neuroinflammation. 6, 1–13 (2009).
4. Karlawish, J., Jack, C. R., Rocca, W. A., Snyder, H. M. & Carrillo, M. C. Alzheimer’s disease: The next frontier—Special Report 2017. Alzheimers Dement 13, 374–380. https://doi.org/10.1016/j.jalz.2017.02.006 (2017).
5. Oset-Gasque, M. J. & Marco-Contelles, J. Alzheimer’s Disease, the “One-Molecule, One-Target” Paradigm, and the Multitarget Directed Ligand Approach. ACS Chem. Neurosci. 9, 401–403. https://doi.org/10.1021/acschemneuro.8b00069 (2018).